Abstract:Objective To explore the VEGF,Flt-1 and KDR mRNA and protein expression in primary gallbladder carcinoma (PGC) and their correlation with primary gallbladder carcinoma clinicopathological characteristics.Methods The VEGF,Flt-1 and KDR mRNA and protein expression in the fresh resected samples of 21 cases of primary gallbladder carcinoma and 10 cases of gallbladder adenomaous ployps (GAP) was deteched by RT-PCR and immunohistochemistry.The correlation between VEGF,Flt-1 and KDR protein positive expression in PGC and the clinicopathological characteristics of PGC was analysed as well.Results The VEGF mRNA positive expression rates in all PGC and GAP cases were 90.47% (19/21) and 20% (2/10),the Flt-1 mRNA positive expression rates were 71.42% (15/21) and 0 (0/10) and the KDR mRNA positive expression rates were 85.71% (18/21) and 10% (1/10),respectively,with the difference being significant between PGC cases and GAP cases (P 0.05).The VEGF protein positive expression rates of all PGC and GAP cases were 80.95% (17/21) and 20% (2/10),the Flt-1 protein positive expression rates were 60.90% (13/21) and 10% (1/10) and the KDR protein positive expression rates were 76.19% (16/21) and 10% (1/10),respectively,with the difference being significant between two groups (P 0.05).The VEGF,Flt-1 and KDR protein positive expression rates in PGC cases with liver infiltration,lymphatic metastasis and Nevin IV and V stages were significantly higher than those in the cases withou liver infiltration,lymphatic metastasis and Nevin I,Ⅱ and Ⅲ stages of PGC (P 0.05).However,the positive expression rates of VEGF,Flt-1[BG)W][LM][BG(][BHDWG8*2,WK42ZQ0W] and KDR protein had no difference among the high,middle and low differentiation of PGC cases (P 0.05).Conclusion The VEGF,Flt-1 and KDR mRNA and protein were all overexpressed in the cases of PGC and the overexpressions of VEGF,Flt-1 and KDR protein were significantly correlated with PGC liver infiltration,lymphatic metastasis and Nevin IV and V stages,but not with the PGC pathological differentiation.

The Expression of Angiogenic Factors PD-ECGF Mrna and VEGF Mrna in Hepatocellular Carcinoma and Portal Vein Tumor Thrombus

Expression of Platelet-Derived Endothelial Cell Growth Factor and Vascular Endothelial Growth Factor in Hepatocellular Carcinoma and Portal Vein Tumor Thrombus

Relationship of HDGF or VEGF expression with hepatocellular carcinoma angiogenesis:report of 108 cases

VEGF, Flt-1 and KDR Mrna and Protein Expression in Primary Gallbladder Carcinoma and Their Correlation with Primary Gallbladder Carcinoma Clinicopathological Characteristics

Heparanase mRNA expression and point mutation in hepatocellular carcinoma

Expression of HIF-1α and VEGF in Hepatocellular Carcinoma and Correlation with Tumor Angiogenesis

HIGH- THROUGHPUT TISSUE MICROARRAY ANALYSIS EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTIOR IN PRIMARY LIVER CANCER AND ITS RELATIONSHIP WITH PROGNOSIS

Tissue microarray analysis of expression of vascular endothelial growth factor and platelet-derived endothelial cell growth factor in a-fetoprotein-negative hepatocellular carcinoma and its relationship with prognosis after radical resection

Expression and Clinical Significance of CD146 and VEGF in Hepatocellular Carcinoma

Significance of Expression of Thrombospondin- 1 and Receptor- CD36 in Hepatocellular Carcinoma

[Expression of Vascular Endothelial Growth Factor Correlates with Invasion and Metastasis of Hepatocellular Carcinoma].

Progress on the molecular mechanism of portal vein tumor thrombosis formation in hepatocellular carcinoma

Prognostic role of expression of angiogenesis markers in hepatocellular carcinoma: A bioinformatics analysis

Protein Expression Profiling of Vascular Endothelial Growth Factor and Its Receptors Identifies Subclasses of Hepatocellular Carcinoma and Predicts Survival

Correlation Between Tumor Perfusion and Vascular Endothelial Growth Factor Expression in Hepatocellular Carcinoma

Expression of extracellular matrix metalloproteinase inducer CD147 and MMP-9 in hepatocellular carcinoma and its clinical significance

Serum Vascular Endothelial Growth Factor is a Predictor of Invasion and Metastasis in Hepatocellular Carcinoma.

[The Effect of Pro-Angiogenic Factors and Their Receptors on Angiogenesis in Hepatocellular Carcinoma].

High Expression of VEGF in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma

Clinical Values of Abnormal Expressions of GPC-3 and HIF-1α in Diagnosis and Prognosis of Hepotacellular Carcinoma

The relationship between plasma levels of pigment epithelial derived factor and vascular endothelial growth factor in the patients with hepatocellular carcinoma and prognosis